Roger Henson

4.6k total citations · 2 hit papers
9 papers, 3.8k citations indexed

About

Roger Henson is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Roger Henson has authored 9 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Roger Henson's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Roger Henson is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Roger Henson collaborates with scholars based in United States, Portugal and Japan. Roger Henson's co-authors include Tushar Patel, Fanyin Meng, Hania Wehbe–Janek, Kalpana Ghoshal, Samson T. Jacob, Joshua T. Mendell, Jinmai Jiang, Thomas D. Schmittgen, Shail Maheshwari and Heather M. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Roger Henson

9 papers receiving 3.7k citations

Hit Papers

MicroRNA-21 Regulates Expression of the PTEN Tumor Suppre... 2006 2026 2012 2019 2007 2006 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Henson United States 8 2.9k 2.8k 493 371 207 9 3.8k
Elisa Callegari Italy 22 2.4k 0.8× 2.1k 0.7× 173 0.4× 223 0.6× 218 1.1× 39 3.1k
Shujun Li China 30 2.4k 0.8× 1.9k 0.7× 237 0.5× 322 0.9× 211 1.0× 134 3.2k
Cheng‐Cao Sun China 31 2.4k 0.8× 2.2k 0.8× 169 0.3× 234 0.6× 182 0.9× 55 3.0k
Jinzhao Ma China 16 2.7k 0.9× 2.4k 0.8× 146 0.3× 201 0.5× 128 0.6× 36 3.2k
Zhaoqun Deng China 31 3.1k 1.1× 2.4k 0.9× 107 0.2× 260 0.7× 220 1.1× 106 3.8k
Alice Conigliaro Italy 25 1.4k 0.5× 958 0.3× 208 0.4× 282 0.8× 153 0.7× 56 2.2k
Minmin Shi China 29 1.1k 0.4× 733 0.3× 198 0.4× 407 1.1× 335 1.6× 81 2.2k
Qinong Ye China 31 2.1k 0.7× 1.2k 0.4× 105 0.2× 536 1.4× 229 1.1× 117 2.9k
He‐Xin Yan China 26 1.4k 0.5× 644 0.2× 429 0.9× 631 1.7× 387 1.9× 53 2.6k

Countries citing papers authored by Roger Henson

Since Specialization
Citations

This map shows the geographic impact of Roger Henson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Henson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Henson more than expected).

Fields of papers citing papers by Roger Henson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Henson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Henson. The network helps show where Roger Henson may publish in the future.

Co-authorship network of co-authors of Roger Henson

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Henson. A scholar is included among the top collaborators of Roger Henson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Henson. Roger Henson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Henson, Roger, et al.. (2009). Epigallocatechin‐gallate modulates chemotherapy‐induced apoptosis in human cholangiocarcinoma cells. Liver International. 29(5). 670–677. 41 indexed citations
2.
Meng, Fanyin, Roger Henson, & Tushar Patel. (2007). Chemotherapeutic stress selectively activates NF-κB-dependent AKT and VEGF expression in liver cancer-derived endothelial cells. American Journal of Physiology-Cell Physiology. 293(2). C749–C760. 24 indexed citations
3.
Meng, Fanyin, Roger Henson, Hania Wehbe–Janek, et al.. (2007). MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology. 133(2). 647–658. 2264 indexed citations breakdown →
4.
Meng, Fanyin, Roger Henson, Hania Wehbe–Janek, et al.. (2007). The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes. Journal of Biological Chemistry. 282(11). 8256–8264. 167 indexed citations
5.
Meng, Fanyin, Hania Wehbe–Janek, Roger Henson, Heather M. Smith, & Tushar Patel. (2007). Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 27(3). 378–386. 201 indexed citations
6.
Henson, Roger, et al.. (2006). Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression. Cancer Research. 66(21). 10517–10524. 181 indexed citations
7.
Henson, Roger, et al.. (2006). Pifithrin-α Enhances Chemosensitivity by a p38 Mitogen-Activated Protein Kinase-Dependent Modulation of the Eukaryotic Initiation Factor 4E in Malignant Cholangiocytes. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1153–1161. 6 indexed citations
8.
Henson, Roger, et al.. (2006). Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. Journal of Hepatology. 46(2). 222–229. 74 indexed citations
9.
Meng, Fanyin, Roger Henson, Shail Maheshwari, et al.. (2006). Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines. Gastroenterology. 130(7). 2113–2129. 826 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026